300 related articles for article (PubMed ID: 16585475)
1. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
[TBL] [Abstract][Full Text] [Related]
2. The effects of pharmacologically induced hypogonadism on mood in healthy men.
Schmidt PJ; Berlin KL; Danaceau MA; Neeren A; Haq NA; Roca CA; Rubinow DR
Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically induced hypogonadism and sexual function in healthy young women and men.
Schmidt PJ; Steinberg EM; Negro PP; Haq N; Gibson C; Rubinow DR
Neuropsychopharmacology; 2009 Feb; 34(3):565-76. PubMed ID: 18354393
[TBL] [Abstract][Full Text] [Related]
4. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men.
Burris AS; Banks SM; Carter CS; Davidson JM; Sherins RJ
J Androl; 1992; 13(4):297-304. PubMed ID: 1399830
[TBL] [Abstract][Full Text] [Related]
5. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
[TBL] [Abstract][Full Text] [Related]
6. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
[TBL] [Abstract][Full Text] [Related]
7. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.
Almeida OP; Waterreus A; Spry N; Flicker L; Martins RN
Psychoneuroendocrinology; 2004 Sep; 29(8):1071-81. PubMed ID: 15219659
[TBL] [Abstract][Full Text] [Related]
8. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
9. The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m-chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men.
Schmidt PJ; Raju J; Danaceau M; Murphy DL; Berlin RE
Neuropsychopharmacology; 2002 Nov; 27(5):800-12. PubMed ID: 12431854
[TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
11. Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study.
Mauras N; Hayes VY; Vieira NE; Yergey AL; O'Brien KO
J Bone Miner Res; 1999 Apr; 14(4):577-82. PubMed ID: 10234579
[TBL] [Abstract][Full Text] [Related]
12. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
[TBL] [Abstract][Full Text] [Related]
13. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women.
Ben Dor R; Harsh VL; Fortinsky P; Koziol DE; Rubinow DR; Schmidt PJ
Am J Psychiatry; 2013 Apr; 170(4):426-33. PubMed ID: 23545794
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
[TBL] [Abstract][Full Text] [Related]
16. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
17. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
Goldstat R; Briganti E; Tran J; Wolfe R; Davis SR
Menopause; 2003; 10(5):390-8. PubMed ID: 14501599
[TBL] [Abstract][Full Text] [Related]
18. The effects of exogenous testosterone on sexuality and mood of normal men.
Anderson RA; Bancroft J; Wu FC
J Clin Endocrinol Metab; 1992 Dec; 75(6):1503-7. PubMed ID: 1464655
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
20. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
Asscheman H; Gooren LJ
Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
